Jay Teich is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between May 2012 and Oct 2018: SEAHORSE BIOSCIENCE INC (North Billerica, MA — biotechnology — 2012–2013; $11.3M reported sold to 29 investors) and Axion BioSystems, Inc. (Atlanta, GA — biotechnology — 2018; $8M reported sold to 31 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $19.3M sold in total.
Listed alongside Andrew Neilson (2 shared filings), David Ferrick (2 shared filings), David Stone (2 shared filings), Earl R. Lewis (2 shared filings), Fouad Azzam (2 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jay. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 12 court cases matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 17 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Jay Teich and found 4 differences: Bankruptcy case: David J. Ferrick and Joanne F. Ferrick; Form D filed 17 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.